A researcher in a lab looking at a tablet.

ALK+ Blog/News

  • Patient Spotlight: Debra Montague, Watchet, United Kingdom

    In this very interesting interview, Debra Montague, Chairman and Founder of ALK Positive UK (https://www.alkpositive.org.uk/), talks to us about starting and establishing the UK-based charity from the ground up, their

    Read More

  • Identifying and understanding EML4-ALK variants and TP53 mutations to optimize treatment of ALK fusion positive (ALK+) NSCLC

    Identifying and understanding EML4-ALK variants and TP53 mutations to optimize treatment of ALK fusion positive (ALK+) NSCLC

    Read More

  • A scientist in a lab looking through a microscope and writing on a clipboard.

    Are there any new Clinical Trials recruiting for ALK-positive lung cancer?

    Clinical trials for more advanced ALK inhibitors, like the TPX-131 study recruiting in Australia and the US, are exciting because they improve on drugs we know work well for ALK-positive

    Read More

  • Gilteritinib overcomes Lorlatinib resistance in ALK-rearranged cancer

    by Mizuta et al. (Japan) A common problem we face is that cancer becomes resistant to our TKIs (Crizotinib, Brigatinib, Alectinib, Ceritinib, and Lorlatinib) over time. There are two known

    Read More

  • So what about immunotherapy?

    The hot phrase in cancer treatment is immunotherapy right now. What does it mean for ALK+patients?  Sometimes, you hear that immunotherapy does not work? But why are we trying to

    Read More

  • The Caregiver Journey

    The Center for Disease Control (CDC) defines the caregiver as providing care to people who need some degree of ongoing assistance with everyday tasks on a daily basis. It is

    Read More

  • ,

    Dr. Vincent Lam at ALKtALK

    Director, Esophageal Cancer Research Program, Assistant Professor of Oncology Expertise: Esophageal Cancer & Lung cancer  Dr Lam: I am so excited to join your conversation tonight on a Sunday evening. 

    Read More

  • Patient Spotlight: Jamie Gibbard, Kent, United Kingdom

    Meet Jamie, one of our international group members and an active volunteer for ALK Positive. Jamie was interviewed about his journey with lung cancer, sharing how volunteering for a purpose

    Read More

  • Stronger Together: ALK+ (Virtual) Summit 2021 July 31 & Aug 1

    TWO AMAZING DAYS of Knowledge, Hope, Sharing & Connection REGISTRATION IS FREE! DAY 1_SATURDAY AGENDA: (All times Eastern Standard)10:00am-11:00am (EST) Welcome! We are kicking off our ALK Summit 2021 with

    Read More

  • ,

    Dr. Benjamin Levy & NPC Rasheda Persinger join ALKtALK

    BENJAMIN PHILLIP LEVY, MD, Clinical Director of Medical Oncology Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital Associate Professor of Oncology RASHEDA PERSINGER, Nurse Practitioner Johns Hopkins Sidney

    Read More

  • The cover to Translational Lung Cancer Research.

    ALK Genetics 101

    About two years ago (before Dr. Ken Culver was hired as ALK Positive Inc Director of Research and Clinical Affairs, and Colin Barton was still leading the ALK Positive Inc Medical Committee), Colin received an email from Dr. Justin Gainor and Dr. Jessica Lin from Massachusetts General Hospital, inviting ALK Positive Inc to contribute to…

    Read More

  • Hope for ALK+ NSCLC Patients

    It’s important that we generate our own hope throughout the challenges and difficulties of ALK+ NSCLC.  Oh yes, there is plenty to be hopeful about on the research and treatment

    Read More